 Serum Autoantibodies Positivity Pevalence in Patients With Chronic HCV and Impact on Pegylated Interferon and Ribavirin Tretment Response: Khairy M, El-Raziky M, El-Akel W, Abdelbary M, Khatab H, El-Kholy B, Esmat G, M Mabrouk. Liver Int. 2013 May 22.

Citation:
,  Serum Autoantibodies Positivity Pevalence in Patients With Chronic HCV and Impact on Pegylated Interferon and Ribavirin Tretment Response: Khairy M, El-Raziky M, El-Akel W, Abdelbary M, Khatab H, El-Kholy B, Esmat G, M Mabrouk. Liver Int. 2013 May 22., , 2013.